These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 10424244

  • 1. The role of B-cells in experimental myasthenia gravis in mice.
    Wang HB, Li H, He B, Bakheit M, Levi M, Wahren B, Berglöf A, Sandstedt K, Link H, Shi FD.
    Biomed Pharmacother; 1999 Jun; 53(5-6):227-33. PubMed ID: 10424244
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The Th2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravis.
    Balasa B, Deng C, Lee J, Christadoss P, Sarvetnick N.
    J Immunol; 1998 Sep 15; 161(6):2856-62. PubMed ID: 9743346
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY, Qiao J, Melms A, Link H.
    Cell Immunol; 1993 Dec 15; 152(2):394-404. PubMed ID: 8258147
    [Abstract] [Full Text] [Related]

  • 7. Animal models of myasthenia gravis.
    Christadoss P, Poussin M, Deng C.
    Clin Immunol; 2000 Feb 15; 94(2):75-87. PubMed ID: 10637092
    [Abstract] [Full Text] [Related]

  • 8. Preferential use of a T cell receptor V beta gene by acetylcholine receptor reactive T cells from myasthenia gravis-susceptible mice.
    Infante AJ, Levcovitz H, Gordon V, Wall KA, Thompson PA, Krolick KA.
    J Immunol; 1992 Jun 01; 148(11):3385-90. PubMed ID: 1375242
    [Abstract] [Full Text] [Related]

  • 9. Role for interferon-gamma in rat strains with different susceptibility to experimental autoimmune myasthenia gravis.
    Wang HB, Shi FD, Li H, van der Meide PH, Ljunggren HG, Link H.
    Clin Immunol; 2000 May 01; 95(2):156-62. PubMed ID: 10779409
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells.
    Duan RS, Adikari SB, Huang YM, Link H, Xiao BG.
    Neurobiol Dis; 2004 Jul 01; 16(2):461-7. PubMed ID: 15193302
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis.
    Xiao BG, Duan RS, Zhu WH, Lu CZ.
    Cell Immunol; 2006 Jun 01; 241(2):95-101. PubMed ID: 17005165
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Experimental autoimmune myasthenia gravis in B10.BV8S2 transgenic mice: preferential usage of TCRAV1 gene by lymphocytes responding to acetylcholine receptor.
    Kaul R, Wu B, Goluszko E, Deng C, Dedhia V, Nabozny GH, David CS, Rimm IJ, Shenoy M, Haqqi TM, Christadoss P.
    J Immunol; 1997 Jun 15; 158(12):6006-12. PubMed ID: 9190955
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. T-bet deficiency decreases susceptibility to experimental myasthenia gravis.
    Liu R, Hao J, Dayao CS, Shi FD, Campagnolo DI.
    Exp Neurol; 2009 Dec 15; 220(2):366-73. PubMed ID: 19818352
    [Abstract] [Full Text] [Related]

  • 19. Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) in rats nasally tolerized against experimental autoimmune myasthenia gravis (EAMG).
    Ma CG, Zhang GX, Xiao BG, Link H.
    Clin Exp Immunol; 1996 Jun 15; 104(3):509-16. PubMed ID: 9099937
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.